Tags: Novo Nordisk
Novo Nordisk Announces $4.1 Billion Investment in North Carolina for Wegovy and Ozempic Production Boost
Novo Nordisk announced a $4.1 billion investment to build a new manufacturing plant in Clayton, North Carolina, to increase production capacity for its popular drugs Wegovy, Ozempic, and other injectable therapies.
Novo Nordisk CEO to Testify Before Senate After Sanders' Subpoena Threat Over Drug Pricing
Novo Nordisk CEO Lars Fruergaard Jørgensen will testify before the Senate following Sen. Bernie Sanders' threat to subpoena the company over the pricing of diabetes drug Ozempic and obesity drug Wegovy.
Telehealth Startup Ro Develops Online Tracker to Combat Wegovy Shortages Amid Weight-Loss Drug Demand
Telehealth startup Ro has launched a free online tracker to help patients and doctors locate in-stock weight-loss drugs like Wegovy amid national shortages, providing real-time availability and the option to report outages to the FDA.
Amgen Challenges Novo Nordisk, Eli Lilly in Weight Loss Drug Market as Investors Flock for Next Obesity Drug Payout
Amgen witnessed an impressive 12% surge in its shares on Friday, marking its most substantial single-day increase in nearly 15 years.







